The Short-Form Leeds Dyspepsia Questionnaire validation study

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 4, 2007, Pages 477-486

  Fraser, A ^a   Delaney, B C ^a   Ford, A C ^b   Qume, M ^a   Moayyedi, P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DYSPEPSIA; ENDOSCOPY; FEMALE; GENERAL PRACTITIONER; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SENSITIVITY ANALYSIS; SHORT FORM LEEDS DYSPEPSIA QUESTIONNAIRE; SYMPTOMATOLOGY; VALIDITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 33846610512     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03233.x     Document Type: Article

References (42)

1. Delaney BC, Moayyedi P, Deeks J, et al. The management of dyspepsia: a systematic review. Health Technol Assess 2000; 4: 1-189.
2. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut 2002; 50: 72iv-8.
3. Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preference for health states. Oper Res 1982; 30: 1043-69.
4. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998; 316: 736-41.
5. Fraser A, Delaney B, Moayyedi P. Symptom-based outcome measures for dyspepsia and GERD trials: a systematic review. Am J Gastroenterol 2005; 100: 442-52.
6. Agreus L. Natural history of dyspepsia. Gut 2002; 50: 2iv-9.
7. Sharma N, Donnellan C, Preston C, Delaney B, Duckett G, Moayyedi P. A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials. Gut 2004; 53 (Suppl. 4): iv58-65.
8. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994; 106: 1174-83.
9. McColl E. Best Practice in Symptom Assessment: a review. Gut 2004; 53 (Suppl. 4): iv49-54.
10. Moayyedi P, Duffett S, Braunholtz D, et al. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther 1998; 12: 1257-62.
11. Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 52-7.
12. Moayyedi P. Helicobacter pylori Eradication in General Practice: Medical Benefits and Health Economics. Leeds: Institute of Epidemiology and Health Services Research, University of Leeds, 1999.
13. Office of the Deputy Prime Minister. The English Indices of Deprivation. London: Neighbourhood Renewal Unit, 2004.
14. Heading RC. Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol Suppl 1999; 231: 3-8.
15. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/ International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999; 231: 20-8.
16. Talley Colin-Jones NJD, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 145-60.
17. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998; 2: 1-74.
18. Management of dyspepsia: report of a working party. Lancet 1988; 1: 576-9.
19. Buckley MJ, Scanlon C, McGurgan P, O'Morain CA. A validated dyspepsia symptom score. Ital J Gastroenterol Hepatol 1997; 29: 495-500.
20. Poitras MR, Verrier P, So C, Paquet S, Bouin M, Poitras P. Group counseling psychotherapy for patients with functional gastrointestinal disorders: development of new measures for symptom severity and quality of life. Dig Dis Sci 2002; 47: 1297-307.
21. Calvet X, Bustamante E, Montserrat A, et al. Validation of phone interview for follow-up in clinical trials on dyspepsia: evaluation of the Glasgow Dyspepsia Severity Score and a Likert-scale symptoms test. Eur J Gastroenterol Hepatol 2000; 12: 949-53.
22. Dent J. Definitions of reflux disease and its separation from dyspepsia. Gut 2002; 50: 17iv-20.
23. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45 (Suppl. 2): II37-42.
24. Greatorex R, Thorpe JA. Clinical assessment of gastro-oesophageal reflux by questionnaire. Br J Clin Pract 1983; 37: 133-5.
25. Junghard O, Lauritsen K, Talley NJ, Wiklund IK. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non-ulcer dyspepsia. Eur J Surg Suppl 1998; 583: 106-11.
26. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-47.
27. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ III. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990; 65: 1456-79.
28. Hu WH, Lam KF, Wong YH, et al. The Hong Kong index of dyspepsia: a validated symptom severity questionnaire for patients with dyspepsia. J Gastroenterol Hepatol 2002; 17: 545-51.
29. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 681-7.
30. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther 1998; 12: 1067-78.
31. Goldman J, Conrad DF, Ley C, et al. Validation of Spanish language dyspepsia questionnaire. Dig Dis Sci 2002; 47: 624-40.
32. Garratt AM, Ruta DA, Russell I, et al. Developing a condition-specific measure of health for patients with dyspepsia and ulcer-related symptoms. J Clin Epidemiol 1996; 49: 565-71.
33. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995; 82: 216-22.
34. Leidy NK, Farup C, Rentz AM, Ganoczy D, Koch KL. Patient-based assessment in dyspepsia: development and validation of Dyspepsia Symptom Severity Index (DSSI). Dig Dis Sci 2000; 45: 1172-9.
35. Rabeneck L, Wristers K, Goldstein JL, Eisen G, Dedhiya SD, Burke TA. Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy. Am J Gastroenterol 2002; 97: 32-9.
36. Drossman DA. The functional gastrointestinal disorders and the Rome III Process. Gastroenterology 2006; 130: 1377-90.
37. Vakil N, VanZanten S, John D, Kahrilas P, Roger J. The Definition of GERD: a Global, Evidence-based Consensus. Los Angeles, USA: Digestive Disease Week, 2006.
38. Rabeneck L, Cook KF, Wristers K, Souchek J, Menke T, Wray NP. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health. J Clin Epidemiol 2001; 54: 755-65.
39. Rothman M, Farup C, Stewart W, Helbers L, Zeldis J. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci 2001; 46: 1540-9.
40. Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 1998; 93: 1409-15.
41. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997; 112: 1798-810.
42. Penston JG. Review article: Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment Pharmacol Ther 1996; 10: 469-86.